期刊文献+

肺癌脑转移86例预后因素分析 被引量:6

下载PDF
导出
摘要 目的:探讨影响肺癌脑转移预后的因素。方法:回顾分析我院2007年1月至2011年12月86例肺癌脑转移患者的临床资料,根据治疗方法不同分为未治疗组(24例)、放疗组(32例)和放疗+化疗组(30例),随访患者的生存时间,并分析影响患者预后的因素。结果:未治疗组、单纯放疗组、放疗+化疗组患者的中位生存期分别为2.0个月、3.5个月、15.5个月,放疗+化疗组患者的生存期明显长于未治疗组和放疗组(P<0.01)。Cox模型逐步法分析显示,RPA分级、诊断肺癌时有无症状、贫血、治疗方法和吸烟史是肺癌脑转移的独立预后因素。结论:积极治疗(放疗+化疗)可延长患者生存时间;肺癌脑转移患者无吸烟史、无症状、RPA分级Ⅰ级为良好预后因素,在治疗过程中应预防或积极纠正贫血。
出处 《承德医学院学报》 2014年第3期220-221,共2页 Journal of Chengde Medical University
关键词 肺癌 脑转移 预后
  • 相关文献

参考文献2

二级参考文献12

  • 1Bex A, Sonke GS, Pos FJ, et al. Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review [J]. Ann Onc, 2010,21 ( 11 ) :2240-2245.
  • 2Pechoux CL, Laplanche A, Faivre CF, et al. Clinical neurological out-come and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase Ⅲ trial( PCI99-01 ,EORTC 22003-08004, RTOG 0212 and IFCT 99-01 ) [J]. Ann Onc.2011.22 (5), 1154-1163.
  • 3Sherif Y, Sharouni EL, Henk BK, et al. Concurrent versus Sequential Chemotherapy and Radiotherapy in Limited Disease Small Cell Lung Cancer: A Retrospective Comparative Study [ J]. Anticaneer Res, 2009,29(12) :5219-5224.
  • 4Nishino M, Jackman DM, Hatabu H, et al. New response evaluation criteria in solid tumors (RECIST) guidelines for advanced small cell lung cancer:comparison with original RECIST and impact on assessment of tumor response to targeted therapy [J]. Am J Roentgenol, 2010,195 (3) :221-228.
  • 5Sahmoun AE, Case LD, Chavour S, et al. Hypertension and Risk of Brain Metastasis from Small Cell Lung Cancer: A Retrospective Follow-up Study [J]. Anticancer Res,2004,24(5B) :3115-3120.
  • 6Postmus PE, Hanny HR, Smit EF, et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy-a phase Ⅲ study of the european organization for the research and treatment of cancer lung cancer cooperative group [ J ]. Clin Oncol,2000,18 ( 19 ) :3400-3408.
  • 7Chen G, Huynh M, Chen A, et al. Chemotherapy for brain metastases in small-cell lung cancer[J]. Clin Lung Cancer,2008,9( 1 ) :35-38.
  • 8Seute T, Leffers P, Wilmink JT, et al. Response of Asymptomatic Brain Metastases From Small-Cell Lung Cancer to Systemic First-Line Chemotherapy [ J ]. J Clin Onco1,2006,24 ( 13 ) :2079-2083.
  • 9Jenkins P, Freeman S. Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer [ J ]. Ann Oncol, 2009,20 ( 1 ) : 34-40.
  • 10Monique LS, Sarah GU, Ronald GH, et al. Evaluation of Chemotherapy-Induced Severe Myelosuppression Incidence in Obese Patients With Capped Dosing[ J ]. J Oncol Pract ,2011,7 ( 1 ) : 13-17.

共引文献18

同被引文献39

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部